51 – 60 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Clinical Trial Update and Novel Therapeutic Approaches for Metastatic Prostate Cancer.
(
- Contribution to journal › Article
- 2010
-
Mark
Effect of a Novel Botanical Agent Drynol Cibotin on Human Osteoblast Cells and Implications for Osteoporosis: Promotion of Cell Growth, Calcium Uptake and Collagen Production
(
- Contribution to journal › Article
-
Mark
Exploring novel therapeutic options in T-LGL, including epigenetic modulation: A case report.
(
- Contribution to journal › Letter
- 2009
-
Mark
Post-translational modification of cyclin A1 is associated with staurosporine and TNFalpha induced apoptosis in leukemic cells.
(
- Contribution to journal › Article
-
Mark
Regulation of Stem Cell Pluripotency and Differentiation Involves a Mutual Regulatory Circuit of the Nanog, OCT4, and SOX2 Pluripotency Transcription Factors With Polycomb Repressive Complexes and Stem Cell microRNAs
(
- Contribution to journal › Scientific review
-
Mark
CYCLIN A1 MEDIATES DRUG-RESISTANT METASTATIC SPREAD OF PCA CELLS IN XENOGRAFTS IN VIVO
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.343-343(
- Contribution to journal › Published meeting abstract
-
Mark
Expression Of Pten And Shp1, Investigated From Tissue Microarrays In Pediatric Acute Lymphoblastic, Leukemia
(
- Contribution to journal › Article
-
Mark
Induction of apoptosis by staurosporine involves the inhibition of expression of the major cell cycle proteins at the G(2)/m checkpoint accompanied by alterations in Erk and Akt kinase activities.
(
- Contribution to journal › Article
-
Mark
Expression of VEGF and VEGF Receptors in Childhood Precursor B-cell Acute Lymphoblastic Leukemia Evaluated by Immunohistochemistry.
(
- Contribution to journal › Article
-
Mark
Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways.
(
- Contribution to journal › Article